Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
83.1M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
33.4M
-
Shares change
-
-647K
-
Total reported value, excl. options
-
$63M
-
Value change
-
-$410K
-
Put/Call ratio
-
10.24
-
Number of buys
-
35
-
Number of sells
-
-38
-
Price
-
$1.89
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 per share (ACET) as of Q4 2023
91 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Adicet Bio, Inc. - Common Stock, par value $0.0001 per share (ACET) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.4M shares
of 83.1M outstanding shares and own 40.16% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (8.32M shares), RTW INVESTMENTS, LP (4.13M shares), MORGAN STANLEY (2.8M shares), COWEN AND COMPANY, LLC (2.72M shares), BlackRock Inc. (2.18M shares), Carlyle Group Inc. (2.12M shares), VANGUARD GROUP INC (1.69M shares), MILLENNIUM MANAGEMENT LLC (1.32M shares), TANG CAPITAL MANAGEMENT LLC (876K shares), and RENAISSANCE TECHNOLOGIES LLC (767K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.